首页> 外国专利> METHOD FOR ASSESSING THE BALANCE OF THE IMMUNE, INFLAMMATORY AND ANTI-INFLAMMATORY REACTION OF ALVEOLAR MACROPHAGES RECOVERED FROM RESECTED PARTS OF THE LUNG OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS, DEPENDING ON THE DEGREE OF MYCOBACTERIUM TUBERCULOSIS MACROPHAGES INFECTION

METHOD FOR ASSESSING THE BALANCE OF THE IMMUNE, INFLAMMATORY AND ANTI-INFLAMMATORY REACTION OF ALVEOLAR MACROPHAGES RECOVERED FROM RESECTED PARTS OF THE LUNG OF PATIENTS SUFFERING PULMONARY TUBERCULOSIS, DEPENDING ON THE DEGREE OF MYCOBACTERIUM TUBERCULOSIS MACROPHAGES INFECTION

机译:评估从肺结核患者肺部切除部位切除的肺小叶巨噬细胞的免疫,炎症和抗炎反应的平衡的方法,取决于真菌肺结核的程度

摘要

FIELD: medicine.;SUBSTANCE: invention refers to medicine, particularly phthisiology, namely to assessing the balance of immune, inflammatory and anti-inflammatory reactions of alveolar macrophages from resected sections of lung patients suffering pulmonary tuberculosis, depending on degree of Mycobacterium tuberculosis macrophage infection. That is ensured by separating alveolar macrophages from the operating lung material, culturing them for 16–18 hours in the wells on the cover glasses, during which a differential coloring is performed, which enables to detect the production of pro-inflammatory (IFNγ, TNFα, IL-1β, IL-12, COX-2), microbicidal (ROS, iNOS), anti-inflammatory (IL-4, IL-10, FGFb) response factors by alveolar macrophages, intensity of macrophagal immune reaction is determined by quantity of alveolar macrophages in ex vivo culture, their infection with mycobacteria, then by share of alveolar macrophages, producing factors of pro-inflammatory, microbicidal, anti-inflammatory reactions, intensity of these reactions is evaluated, at comparison of which with degree of infection of alveolar macrophages with mycobacteria, a conclusion is made on deviation from balance state of said reactions of alveolar macrophages.;EFFECT: invention provides determining redundancy or insufficiency of reactions of alveolar macrophages in response to infection with tuberculosis mycobacteria after chemotherapy and surgical treatment of patients with pulmonary tuberculosis.;1 cl, 9 dwg, 4 tbl, 5 ex
机译:技术领域本发明涉及医学,特别是药理学,即根据结核分枝杆菌巨噬细胞感染的程度评估来自肺结核患者肺切除部分的肺泡巨噬细胞的免疫,炎症和抗炎反应的平衡。 。通过将肺泡巨噬细胞与正在运行的肺部物质分离,并在盖玻片上的孔中培养16–18小时来确保这一点,在此期间进行不同的着色,从而可以检测促炎性物质(IFNγ,TNFα ,IL-1β,IL-12,COX-2),杀微生物(ROS,iNOS),抗炎药(IL-4,IL-10,FGFb)是由肺泡巨噬细胞引起的,巨噬细胞免疫反应的强度由数量决定体外培养的肺泡巨噬细胞的感染,分枝杆菌的感染,然后按肺泡巨噬细胞的份额,产生促炎,杀微生物,抗炎反应的因子,评估这些反应的强度,并与感染的程度进行比较肺泡巨噬细胞与分枝杆菌的关系,得出了所述肺泡巨噬细胞反应平衡状态偏离的结论。效果:本发明提供了确定肺泡巨噬细胞反应的冗余或不足的结论。 es对化疗和手术治疗后的肺结核患者的结核分枝杆菌感染有反应。1cl,9 dwg,4 tbl,5 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号